Investigation on the effectiveness of the Mostgraph and fractional exhaled nitric oxide measurement in chronic cough

C. Nakano, N. Hatanaka, T. Yamagishi, H. Kamemura, N. Kodaka, A. Miura, A. Kitahara, Y. Kurose, K. Sugawa, K. Kashiwa, Y. Kamata, H. Hayashi, M. Toyoda, K. Hirayama, K. Sanno (Tokyo, Japan)

Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases
Session: Exhaled biomarkers in airway diseases
Session type: Thematic Poster Session
Number: 2211
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Nakano, N. Hatanaka, T. Yamagishi, H. Kamemura, N. Kodaka, A. Miura, A. Kitahara, Y. Kurose, K. Sugawa, K. Kashiwa, Y. Kamata, H. Hayashi, M. Toyoda, K. Hirayama, K. Sanno (Tokyo, Japan). Investigation on the effectiveness of the Mostgraph and fractional exhaled nitric oxide measurement in chronic cough. Eur Respir J 2012; 40: Suppl. 56, 2211

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The role of exhaled nitric oxide in the evaluation of chronic cough
Source: Eur Respir J 2006; 28: Suppl. 50, 794s
Year: 2006

Clinical utility of fractional exhaled nitric oxide in severe asthma management
Source: Eur Respir J, 55 (3) 1901633; 10.1183/13993003.01633-2019
Year: 2020



Same-day repeatability of fractional exhaled nitric oxide in severe asthma
Source: Eur Respir J, 57 (5) 2003391; 10.1183/13993003.03391-2020
Year: 2021



Effect of caffeine on exhaled nitric oxide measurements in asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 180s
Year: 2003

Mechanisms of decrease in fractional exhaled nitric oxide during acute bronchoconstriction
Source: Annual Congress 2010 - Asthma: breath biomarkers and asthma control
Year: 2010

Reproducibility of exhaled nitric oxide measurements in healthy and asthmatic adults and children
Source: Eur Respir J 2003; 21: 433-438
Year: 2003



Fractional exhaled nitric oxide is associated with more severe asthma
Source: International Congress 2018 – Biomarkers for evaluating asthma
Year: 2018

Predicting response to corticosteroid in COPD using exhaled nitric oxide
Source: Annual Congress 2009 - Drug effects in COPD
Year: 2009


Nasal nitric oxide, exhaled nitric oxide and exhaled breath condensate pH measurements in children with allergic disease
Source: Annual Congress 2008 - Clinical utility of exhaled nitric oxide measurement
Year: 2008

Measurement of exhaled nitric oxide in children
Source: Guideline 2002
Year: 2002

Exhaled nitric oxide in the differential diagnosis of chronic cough
Source: Annual Congress 2007 - Noninvasive evaluation of airway diseases
Year: 2007


Fractional exhaled nitric oxide in bronchiectasis
Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases
Year: 2012


Clinical utility of exhaled nitric oxide fraction in the management of asthma and COPD
Source: Breathe, 15 (4) 306; 10.1183/20734735.0268-2019
Year: 2019



Levels of asthma control and exhaled nitric oxide
Source: Annual Congress 2009 - Airway inflammation and asthma control
Year: 2009

The use of exhaled nitric oxide concentration as a means of excluding eosinophilic inflammation in chronic cough
Source: Annual Congress 2009 - From cough to sound analysis of breathing
Year: 2009

Clinical usefulness of fractional exhaled nitric oxide (FeNO) as a marker of long-term asthma control
Source: Annual Congress 2009 - Airway inflammation and asthma control
Year: 2009

Fractional exhaled nitric oxide for eosinophilic inflammation in stable COPD
Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers
Year: 2017


Fractional exhaled nitric oxide (FeNO) for an early diagnosis of asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 677s
Year: 2006